The sales decline was attributed to revenue loss from its biologics and clinical therapies business line, which spun off and was branded Bioventus. Broken out by business line, sales from Smith & Nephew’s knee products fell 1 percent, while its sports medicine products saw an 8 percent hike.
More Articles on Orthopedic Devices:
NeuroMetrix Signs Distribution Agreement for Pain Management Device
